Elsevier

Journal of Neuroimmunology

Volume 299, 15 October 2016, Pages 1-7
Journal of Neuroimmunology

Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection

https://doi.org/10.1016/j.jneuroim.2016.08.003Get rights and content

Highlights

  • We found a significant main effect for Toxoplasmosis and HIV on cognitive performance

  • In HIV-infected participants lower T. gondii IgG levels were associated with worse cognitive performance

  • Latent toxoplasmosis was not associated with behavioral changes and risk-taking behaviors in study participants

  • In HIV-infected patients, latent toxoplasmosis is a risk factor for neurocognitive impairment

Abstract

We evaluated the impact of latent toxoplasmosis (LT) on neurocognitive (NC) and neurobehavioural functioning in young adults with and without chronic HIV infection, using a standardised NC test battery, self-reported Beck Depression Inventory, Frontal System Behavior Scale, MINI-International Neuropsychiatric Interview and risk-assessment battery.

194 young adults (median age 24 years, 48.2% males) with chronic HIV infection (HIV +) since childhood and 51 HIV seronegative (HIV −) participants were included. HIV + individuals had good current immunological status (median CD4: 479 cells/μl) despite a low CD4 nadir (median: 93 cells/μl). LT (positive anti-Toxoplasma IgG antibodies) was present in one third of participants. The impairment rates in the HIV − with and without Toxo were not significantly different (p = 0.17). However, we observed an increasing trend (p < 0.001) in impairment rates with HIV and LT status: HIV −/LT − (6.1%); HIV −/LT + (22%), HIV +/LT − (31%), HIV +/LT + (49%). In a multivariable analysis using the entire study group there were main effects on cognition for HIV and also for LT. Within the HIV + group LT was associated with worse performance globally (p = 0.006), in memory (p = 0.009), speed of information processing (p = 0.01), verbal (p = 0.02) and learning (p = 0.02) domains. LT was not associated with depressive symptoms, frontal systems dysfunction or risk behaviors in any of the groups. HIV participants with lower Toxoplasma antibody concentration had worse NC performance, with higher GDS values (p = 0.03) and worse learning (p = 0.002), memory (p = 0.006), speed of information processing (p = 0.01) T scores.

Latent Toxoplasmosis may contribute to NC impairment in young adults, including those with and without chronic HIV infection.

Introduction

Latent Toxoplasma gondii (LT) infection had long been assumed to be asymptomatic, but increased evidence links its presence to increased risk for psychiatric conditions such as schizophrenia (Nimgaonkar & Yolken, 2012), bipolar disorder (Dickerson et al., 2014) and suicidal behavior (Okusaga and Postolache, 2012, Zhang et al., 2012). The presence of Toxoplasma gondii antibodies has also been associated with neurodegenerative syndromes such as Parkinson's Disease (Miman et al., 2010).

Several studies reported the association between Toxoplasma gondii seropositivity and poor cognitive scores, especially in certain groups of people with low-income (Pearce et al., 2014) and low education (Gale et al., 2014a). Worse performance on cognitive tests associated with Toxoplasma gondii was reported for reaction time, concentration (Havlicek et al., 2001), learning and memory (Gajewski et al., 2014). Moreover, latent toxoplasmosis was associated with impulsive behaviours such as higher risk for work- and traffic- accidents (Alvarado-Esquivel et al., 2012, Flegr, 2013, Yereli et al., 2006).

Toxoplasma gondii tachyzoites are capable of invading microglia, astrocytes, and neurons (Koshy & Cabral, 2014); the parasite thereafter forms cysts within these cells (Luder et al., 1999, Carruthers and Suzuki, 2007). Parasite strains can differ greatly in their aggressiveness during infection and in their propensity to form cysts for long-term survival (Song et al., 2013). Significant production of dopamine by Toxoplasma gondii induces increased production of tachyzoites and destruction of cyst walls (Strobl et al., 2012) and may be responsible for behavioural changes (Prandovszky et al., 2011). Higher anti-Toxoplasma antibody levels have correlated with more severe psychiatric symptoms (Hinze-Selch et al., 2010, Hinze-Selch et al., 2007), although the relationship between antibody levels and cognition is not always clear (Havlicek et al., 2001).

Almost half of the HIV-infected population has neurocognitive (NC) impairment, typically mild to moderate in severity (Heaton et al., 2010, Chan and Brew, 2014). While conditions like ageing, drug abuse and chronic hepatitis C can contribute to NC impairment in HIV-infected patients (Schuster & Gonzalez, 2012), the influence of LT has received only limited attention (Bharti et al., 2012).

We aimed to evaluate the contribution of latent infection with Toxoplasma gondii on NC performance and neuropsychiatric conditions (depression and suicidal risk, conditions associated with frontal-subcortical circuitry damage and risk taking behaviors) in a group of young adults with and without chronic HIV infection since childhood.

Section snippets

Study participants

We included in the current study all 194 HIV + and 51 HIV −, age-matched participants recruited until 1-Oct-2014 in a cross-sectional study of the long-term effects of chronic HIV infection on the developing brain. The HIV + participants had previously documented HIV infection, epidemiological data supporting parenteral non-IDU route of HIV transmission during the Romanian HIV Paediatric epidemic. Inclusion criteria were: at least 8 years of education, no NC impairment unrelated to HIV or

HIV + and HIV − group characteristics

Demographic and disease characteristics are summarized in Table 1. HIV + and HIV − participants did not differ in age, gender, or body mass index (BMI). Three participants had chronic hepatitis C infection; none had current or past Toxoplasma encephalitis.

The prevalence of positive Toxoplasma IgG antibodies was 35.3% in the HIV − group and 32.4% in the HIV + group. None of the participants had IgM antibodies.

Overall, NCI was more common among HIV + subjects, compared to HIV − participants (36.5% vs.

Discussion

In this analysis of nearly 250 HIV + and HIV − adults, we found latent Toxoplasmosis was associated with worse overall cognitive performance. While HIV + participants as a group performed more poorly than the HIV- participants, the presence of anti-Toxoplasma IgG antibodies was also associated with a significantly higher rate of overall impairment in HIV + individuals, supporting the hypothesis that latent Toxoplasma infection contributes to the brain injury that can occur in adults with chronic

Funding

This work was supported by 1R01MH094159 and P30 MH62512 from National Institute of Mental Health.

Authors declaration

I, Luminita Ene certify herby that this manuscript contains original work and that it has not been published or submitted for publication elsewhere.

Acknowledgements

We also want to thank to all the participants in the study, Mr. Terence Hendrix from the HIV Neurobehavioural Research Center, Drs., Roxana Radoi, Ruxandra Burlacu, Simona Tetradov and Psych. Anca Luca, Psych Adina Bulacu-Talnariu, Psych. Adrian Luca for neurocognitive and neuropsychological testing.

This work was presented in part at the 13th International Symposium on NeuroVirology, June 2-6, 2015 San Diego, California, USA, abstract P40.

References (55)

  • OkusagaO. et al.

    Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia

    Schizophr. Res.

    (2011)
  • YagmurF. et al.

    May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects?

    Forensic Sci. Int.

    (2010)
  • YereliK. et al.

    Is Toxoplasma gondii a potential risk for traffic accidents in Turkey?

    Forensic Sci. Int.

    (2006)
  • AlfonzoM. et al.

    Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model

    Clin. Exp. Immunol.

    (2002)
  • Alvarado-EsquivelC. et al.

    High seroprevalence of Toxoplasma gondii infection in a subset of Mexican patients with work accidents and low socioeconomic status

    Parasite Vectors

    (2012)
  • ArlingT.A. et al.

    Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders

    J. Nerv. Ment. Dis.

    (2009)
  • BeckA.T. et al.

    Beck Depression Inventory Manual

    (1993)
  • BhartiA. et al.

    Latent toxoplasmosis may affect neurocognitive functioning in HIV-positive individuals

  • CareyC.L. et al.

    Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

    J. Clin. Exp. Neuropsychol.

    (2004)
  • CarruthersV.B. et al.

    Effects of Toxoplasma gondii infection on the brain

    Schizophr. Bull.

    (2007)
  • ChanP. et al.

    HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment

    Curr. HIV/AIeDS Rep.

    (2014)
  • CrucerescuE.

    Epidemiological data on toxoplasmosis. The aspects of congenital toxoplasmosis

    Bacteriol. Virusol. Parazitol. Epidemiol.

    (1998)
  • DickersonF. et al.

    Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls

    J. Nerv. Ment. Dis.

    (2014)
  • DubeyJ.P. et al.

    Epidemiological review of toxoplasmosis in humans and animals in Romania

    Parasitology

    (2014)
  • El LakkisI. et al.

    Association between latent toxoplasmosis and psychiatric disorders in HIV-infected subjects

    J. Acquir. Immune Defic. Syndr.

    (2015)
  • EneL. et al.

    Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood

    J. Neurovirol.

    (2014)
  • FurcoA. et al.

    Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART

    AIDS

    (2008)
  • Cited by (21)

    • Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis

      2021, Molecular and Biochemical Parasitology
      Citation Excerpt :

      Toxoplasma gondii is an obligate intracellular parasite that causes opportunistic infections in immune suppressed individuals [1–3].

    • Toxoplasmosis treatment with diphenyl diselenide in infected mice modulates the activity of purinergic enzymes and reduces inflammation in spleen

      2017, Experimental Parasitology
      Citation Excerpt :

      This latent infection by T. gondii is denominated chronic toxoplasmosis, and it is considered an asymptomatic disease (Fergunson and Hutchinson, 1987). Some studies reveal that the small brain inflammation connected to the cysts can induce neurological disorders in rodents (Machado et al., 2016) and humans (Ene et al., 2016). Moreover, the infection reduces serum levels of testosterone (Eslamirad et al., 2013) and increases the levels of pro-inflammatory cytokines, as INF-γ, to prevent a reactivation of the parasites (Barbosa et al., 2014).

    • Hepatic xanthine oxidase activity and purine nucleosides levels as physiological mediators to analyze a subcutaneous treatment with (PhSe)<inf>2</inf> in mice infected by Toxoplasma gondii

      2017, Microbial Pathogenesis
      Citation Excerpt :

      Toxoplasmosis is a disease caused by Toxoplasma gondii, a protozoon that infects animals and humans [1,2]. Chronic toxoplasmosis is characterized by the latent infection of the brain by the parasite, which induces neurological and behavioral disorders in mice and humans [3,4]. This chronic infection is considered asymptomatic, however the latency phase can improve the pro-inflammatory profile by increasing cytokines and others immune factors [5].

    View all citing articles on Scopus
    View full text